ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress

January 20, 1989

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Peers Puzzled By Herberman’s Stance On Cell Phones While Believers Rally.

August 1, 2008

Hammer Says He’ll Demand Construction Funds If Data Supports The Need

August 12, 1983

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004